{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:47:28Z","timestamp":1791920848634,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.femsim.2004.05.001","type":"journal-article","created":{"date-parts":[[2004,5,30]],"date-time":"2004-05-30T02:39:39Z","timestamp":1085884779000},"page":"187-195","source":"Crossref","is-referenced-by-count":24,"title":["The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen<i>Cryptococcus neoformans<\/i>"],"prefix":"10.1093","volume":"42","author":[{"given":"Elisabetta","family":"Blasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Colombari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Francesca Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Pinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonarda","family":"Troiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cossarizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuela","family":"Peppoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Neglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.femsim.2004.05.001-BIB1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(05)78279-9","article-title":"Effect of HAART on natural history of AIDS-related opportunistic disorders","volume":"351","author":"Sepkowitz","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.femsim.2004.05.001-BIB2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.276.5314.960","article-title":"Kinetics of response in lymphoid tissue to antiretroviral therapy of HIV-1 infection","volume":"276","author":"Cavert","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.femsim.2004.05.001-BIB3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(97)07529-6","article-title":"Treatment of HIV-1 associated microsporidiosis with combination antiretroviral therapy","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.femsim.2004.05.001-BIB4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patiens with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.femsim.2004.05.001-BIB5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effect of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Austran","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.femsim.2004.05.001-BIB6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/515244","article-title":"Improvement in cell-mediated immune functions during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir","volume":"177","author":"Angel","year":"1998","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.femsim.2004.05.001-BIB7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/infdis\/173.2.321","article-title":"Alterations in the immune response of HIV-infected subjects treated with HIV-specific protease inhibitor, ritonavir","volume":"173","author":"Kelleher","year":"1996","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.femsim.2004.05.001-BIB8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00042560-199712150-00002","article-title":"Patterns of T-cellrepopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents","volume":"16","author":"Pakker","year":"1997","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol"},{"key":"10.1016\/j.femsim.2004.05.001-BIB9","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1097\/00002030-200012010-00009","article-title":"Normalisation of anti-cryptococcal activity and interleukin production after highly active antiretroviral therapy","volume":"14","author":"Monari","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.femsim.2004.05.001-BIB10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/314871","article-title":"In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors","volume":"180","author":"Cassone","year":"1999","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.femsim.2004.05.001-BIB11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1523-1747.1999.00747.x","article-title":"HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secrete aspartic proteases","volume":"113","author":"Borg-von Zepelin","year":"1999","journal-title":"J. Invest. Dermatol"},{"key":"10.1016\/j.femsim.2004.05.001-BIB12","first-page":"55","article-title":"Candida albicans secreted aspartyl proteinases","volume":"7","author":"Hube","year":"1996","journal-title":"Curr. Top. Med. Mycol"},{"key":"10.1016\/j.femsim.2004.05.001-BIB13","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/IAI.63.5.1887-1892.1995","article-title":"Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis","volume":"63","author":"Bernardis","year":"1995","journal-title":"Infect. Immun"},{"key":"10.1016\/j.femsim.2004.05.001-BIB14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/314546","article-title":"Evidence that members of the secretory aspartyl proteinases gene family (SAP), in particular SAP2, are virulence factors for Candida vaginitis","volume":"179","author":"Bernardis","year":"1999","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.femsim.2004.05.001-BIB15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/infdis\/156.5.777","article-title":"Evidence for a correlation between proteinase secretion and vulvovaginal candidosis","volume":"156","author":"Cassone","year":"1987","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.femsim.2004.05.001-BIB16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01138475","article-title":"Extracellular proteolytic avtivity of Cryptococcus neoformans","volume":"128","author":"Aoki","year":"1994","journal-title":"Mycophatologia"},{"issue":"5","key":"10.1016\/j.femsim.2004.05.001-BIB17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/CDLI.3.5.570-574.1996","article-title":"Extracellular proteinase activity of Cryptococcus neoformans","volume":"3","author":"Chen","year":"1996","journal-title":"Clin. Diagn. Lab. Immunol"},{"issue":"1","key":"10.1016\/j.femsim.2004.05.001-BIB18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3201\/eid0401.980109","article-title":"What makes Cryptococcus neoformans a pathogen","volume":"4","author":"Buchanam","year":"1998","journal-title":"Emerg. Infect. Dis"},{"key":"10.1016\/j.femsim.2004.05.001-BIB19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07388559309069197","article-title":"Yeast extracellular proteases","volume":"13","author":"Ogrydziak","year":"1993","journal-title":"Crit. Rev. Biotechnol"},{"issue":"1","key":"10.1016\/j.femsim.2004.05.001-BIB20","first-page":"79","article-title":"Cryptococcus neoformans: virulence and host defences","volume":"36","author":"Perfect","year":"1998","journal-title":"Med. Mycol"},{"issue":"2","key":"10.1016\/j.femsim.2004.05.001-BIB21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0882-4010(02)00195-X","article-title":"Cleavage of human fibronectin and other basement membrane-associated proteins by Cryptococcusneoformans serine proteinase","volume":"34","author":"Rodrigues","year":"2003","journal-title":"Microb. Pathog"},{"key":"10.1016\/j.femsim.2004.05.001-BIB22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/IAI.66.1.89-97.1998","article-title":"Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes","volume":"66","author":"Franzot","year":"1998","journal-title":"Infect. Immun"},{"issue":"8","key":"10.1016\/j.femsim.2004.05.001-BIB23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s100960100549","article-title":"Evidence of microevolution in a clinical case of recurrent Cryptococcus neoformans meningoencephalitis","volume":"28","author":"Blasi","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"issue":"4","key":"10.1016\/j.femsim.2004.05.001-BIB24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/341564","article-title":"Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia","volume":"186","author":"Chretien","year":"2002","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.femsim.2004.05.001-BIB25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-5728(90)90073-V","article-title":"Immortalization of murine microglial cells by a v-raf\/v-myc carrying retrovirus","volume":"27","author":"Blasi","year":"1990","journal-title":"J. Neuroimmunol"},{"issue":"4","key":"10.1016\/j.femsim.2004.05.001-BIB26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jnr.490310405","article-title":"An immortalized cell line expresses properties of activated microglial cells","volume":"31","author":"Bocchini","year":"1992","journal-title":"J. Neurosci. Res"},{"issue":"9","key":"10.1016\/j.femsim.2004.05.001-BIB27","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1128\/IAI.60.9.3682-3688.1992","article-title":"Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization","volume":"60","author":"Blasi","year":"1992","journal-title":"Infect. Immun"},{"key":"10.1016\/j.femsim.2004.05.001-BIB28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0165-5728(95)00016-U","article-title":"Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 murine line","volume":"58","author":"Blasi","year":"1995","journal-title":"J. Neuroimmunol"},{"issue":"4","key":"10.1016\/j.femsim.2004.05.001-BIB29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s004300100066","article-title":"Nramp1 gene effects selective early steps in macrophage-mediated anti-cryptococcal defense","volume":"189","author":"Blasi","year":"2001","journal-title":"Med. Microbiol. Immunol"},{"key":"10.1016\/j.femsim.2004.05.001-BIB30","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/IAI.63.4.1218-1222.1995","article-title":"Biomolecular events involved in anticryptococcal resistance in the brain","volume":"63","author":"Blasi","year":"1995","journal-title":"Infect. Immun"},{"key":"10.1016\/j.femsim.2004.05.001-BIB31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-5728(00)00319-2","article-title":"Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neofrmans strain","volume":"109","author":"Barluzzi","year":"2000","journal-title":"J. Neuroimmunol"},{"issue":"4","key":"10.1016\/j.femsim.2004.05.001-BIB32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/AAC.41.4.802","article-title":"Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis","volume":"41","author":"Mazzolla","year":"1997","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.femsim.2004.05.001-BIB33","first-page":"189","article-title":"Role of the capsule in microglial cell\u00e2\u0080\u0093Cryptococcus neoformans interaction: impairment of antifungal activity but not secretory functions","volume":"36","author":"Barluzzi","year":"1998","journal-title":"Med. Mycol"},{"key":"10.1016\/j.femsim.2004.05.001-BIB34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0021-9258(17)41059-3","article-title":"A colorimetric method for the determination of the proteolytic activity of duodenal juice","volume":"171","author":"Charney","year":"1947","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.femsim.2004.05.001-BIB35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/bbrc.1993.2438","article-title":"A new method for the cytofluorimetric analyses of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5,6,6\u00e2\u0080\u00b2-tetrachloro-1,1\u00e2\u0080\u00b2,3,3\u00e2\u0080\u00b2-tetraethylbenzimidazolcarbocyanineiodide (JC-1)","volume":"197","author":"Cossarizza","year":"1993","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.femsim.2004.05.001-BIB36","unstructured":"[36] Cossarizza, A., Salvioli, S., Robinson, J.P., Darzynkiewicz, Z., Dean, P., Dressler, L.G., Rabinovitch, P., Stewart, C., Tanke, H., Wheeless, L., Eds. Flow cytometrical analyses of mitochondrial potential membrane. Current Protocols in Cytometry 2000 Wiley 9.14.1, 9147"},{"issue":"13","key":"10.1016\/j.femsim.2004.05.001-BIB37","first-page":"165","article-title":"Inhibition of aspartic protease by pepstatin and 3-methylstatine derivate of pepstatin, evidence for collected-substrate enzyme inhibition","volume":"18,24","author":"Rich","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.femsim.2004.05.001-BIB38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJM199804303381808","article-title":"HIV protease inhibitors","volume":"338","author":"Flexner","year":"1998","journal-title":"N. Engl. J. Med"},{"issue":"13","key":"10.1016\/j.femsim.2004.05.001-BIB39","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1097\/00002030-200109070-00012","article-title":"Direct analysis of mitochondrial toxicity of antiretroviral drugs","volume":"15","author":"Foli","year":"2001","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.femsim.2004.05.001-BIB40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mcp.2000.109391","article-title":"Steady-state pharmacokinetics of indinavir in cerebraospinal fluid and plasma among adults with human immunodeficiency virus type1 infection Clin","volume":"68","author":"Haas","year":"2000","journal-title":"Pharmacol. Ther"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/42\/2\/187\/19167554\/42-2-187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T17:37:56Z","timestamp":1624383476000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1016\/j.femsim.2004.05.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,10]]}},"URL":"https:\/\/doi.org\/10.1016\/j.femsim.2004.05.001","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}